|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Short-term prepaid insurance | ||||
| Total current assets | ||||
| Deferred offering costs | ||||
| Long-term prepaid insurance | ||||
| Cash and marketable securities held in Trust Account | ||||
| Total Assets | ||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) | ||||
| Current liabilities | ||||
| Accrued expenses | ||||
| Accounts payable and accrued expenses | ||||
| Accrued offering costs | ||||
| Promissory note - related party | ||||
| Related Party | ||||
| Total promissory note - related party | ||||
| Total current liabilities | ||||
| Deferred legal fees | ||||
| Total Liabilities | ||||
| Class A ordinary shares subject to possible redemption, 25,300,000 shares and no shares at a redemption value of $10.17 and $0 per share as of June 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders’ Equity (Deficit) | ||||
| Ordinary shares, value | ||||
| Class A Ordinary Shares | ||||
| Class B Ordinary Shares | ||||
| Additional paid-in capital | ||||
| Retained earnings (accumulated deficit) | ||||
| Total Shareholders’ Equity (Deficit) | ||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) |
Loading...
